Recovery of splenic infarction with anti-platelet treatments and platelet-apheresis in polycythemia vera

Transfusion and Apheresis Science

Volumn 34, Issue 2, 2006, Pages 199-202

  Yavasoglu, Irfan ^a   Kadikoylu, Gurhan ^a   Bolaman, Zahit ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Platelet apheresis; Polycythemia vera; Splenic infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALKALINE PHOSPHATASE; ANALGESIC AGENT; ANTITHROMBOCYTIC AGENT; D DIMER; ERYTHROCYTE CR 51; HEMOGLOBIN; HYDROXYUREA; RADIOISOTOPE; VITAMIN B GROUP;

ABDOMINAL PAIN; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; CELL HYPERPLASIA; CHROMOSOME ANALYSIS; CLINICAL OBSERVATION; CONJUNCTIVA; DYSPLASIA; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPEREMIA; LEUKOCYTE; MEGAKARYOCYTE; PHYSICAL EXAMINATION; POLYCYTHEMIA VERA; PRURITUS; SCORING SYSTEM; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPLEEN; SPLEEN INFARCTION; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPHERESIS; THROMBOSIS;

AGED; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PLATELETPHERESIS; POLYCYTHEMIA VERA; SPLENIC INFARCTION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33645982276     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2005.12.002     Document Type: Article

References (22)

1. Means R.T. Polycyhtemia vera. In: Greer J.P., Foerster J.F., Lukens J.N., Rodgers G.M., Paraskevas F., and Gladder B. (Eds). Wintrobe's clinical hematology. 11th ed. (2004), Lippincott Williams, Philadelphia 2258-2272
2. Tefferi A. Polycythemia Vera: a comprehensive review and clinical recommendations. Mayo Clin Proc 78 (2003) 174-194
3. Gruppo Italiano Studio Policitemia (GISP). Polycythemia vera: the natural history of 1213 patients followed over 20 years. Ann Int Med 1995;123:656-664.
4. Finazzi G. A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP). Pathol Biol 52 (2004) 285-288
5. Berk P.D., Goldberg J.D., Donovan P.B., Fruchtman S.M., Berlin N.I., and Wasserman L.R. Therapeutic recommendations in polycythemia vera based on polycythemia study group protocols. Semin Hematol 23 (1986) 132-143
6. Broodmann S., Passweg J.R., Gratwohl A., Tichelli A., and Skoda R.C. Myeloproliferative disorders: complications, survival and causes of death. Ann Hematol 79 (2000) 312-318
7. Nores M., Phillips E.H., Morgenstern L., and Hiatt J.R. The clinical spectrum of splenic infarction. Am Surg 64 (1998) 182-188
8. Athale U.H., Kaste S.C., Bodner S.M., and Ribeiro R.C. Splenic rupture in children with hematologic malignancies. Cancer 88 (2000) 480-490
9. Jama A.H., Salem A.H., and Dabbous I.A. Massive splenic infarction in Saudi patients with sickle cell anemia: a unique manifestation. Am J Hematol 69 (2002) 205-209
10. Mazal B., Amital H., Barkan D., Shaham D., and Leitersdorf E. Splenic infarction as an unusual cause of left pleural effusion. Harefuah 143 (2004) 563-565 (Abstract)
11. Beckett D., Miller C., Ferrando J.R., and Banerjee A.K. Case report: polycythaemia vera presenting as massive splenic infarction and liquefaction. Br J Radiol 77 (2004) 876-877
12. Downer W.R., and Peterson M.S. Massive splenic infarction and liquefactive necrosis complicating polycythemia vera. Am J Roentgenol 161 (1993) 79-80
13. Pearson T.C., and Messinezy M. The diagnostic criteria of polycythaemia rubra vera. Leuk Lymphoma 22 Suppl 1 (1996) 87-93
14. Gorg C., Seifart U., and Gorg K. Acute, complete splenic infarction in cancer patient is associated with outcome. Abdom Imaging 29 (2004) 224-227
15. Toth P.P., Reuter R.K., and MacDonald J. Spontaneous splenic infarction secondary to diabetes-induced microvascular disease. Arch Fam Med 9 (2000) 195-197
16. Jaroch M.T., Broughan T.A., and Hermann R.E. The natural history of splenic infarction. Surgery 100 (1986) 743-750
17. Means J.R., Viella E.R., and Stahfeld K.R. Splenocolic fistula in a patient with polycythemia vera. Am J Surg 185 (2003) 173-174
18. Grima K.M. Therapeutic apheresis in hematological and oncological diseases. J Clin Apher 15 (2000) 28-52
19. Falanga A., Marchetti M., Evangelista V., Vignoli A., Licini M., Balicco M., et al. Polymorphonuclear leukocyte activation and hemostazis in patients with essential thrombocythaemia and polycytemia vera. Blood 96 (2000) 4261-4266
20. Sagripanti A., Ferretti A., Nicoloni A., and Carpi A. Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders. Biomed Pharmacother 50 (1996) 376-382
21. Kadikoylu G., Onbasili A., Tekten T., Barutca S., and Bolaman Z. Functional and morphological cardiac changes in myeloproliferative disorders (clinical study). Int J Cardiol 97 (2004) 213-220
22. Nand S., and Orfei E. Pulmonary hypertension in polycythemia vera. Am J Hematol 47 (1994) 242-244